Cross-reactivity in Adaptive Immunity: An Overview

Cross-reactivity in adaptive immunity refers to the ability of immune cells to recognize and respond to similar but distinct antigens. This phenomenon, while aiding in the recognition and defense against diverse pathogens, can also lead to unintended immune responses, including autoimmune reactions. The review explores key mechanisms underlying cross-reactivity, including molecular mimicry, T cell receptor degeneracy, and antibody cross-recognition. It discusses the dual role of cross-reactivity in infectious diseases, where it contributes to both protective immunity and potential disease enhancement, as seen in infections like dengue and Zika. Cross-reactivity is also implicated in autoimmunity, where immune responses to microbial antigens can mistakenly target self-tissues, potentially triggering conditions such as type 1 diabetes and multiple sclerosis. Additionally, the review addresses the implications of cross-reactivity in vaccine design, emphasizing the need to balance broad immune protection with safety, as well as challenges in immunotherapy where cross-reactivity may lead to off-target effects. Understanding cross-reactivity is essential to leveraging adaptive immunity effectively while minimizing potential adverse effects, with applications spanning infection control, vaccine development, and therapeutic interventions in immune-mediated diseases. Keywords: Adaptive immunity, Cross-reactivity, Molecular mimicry, Autoimmunity, Vaccine development, Immunotherapy